EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, ATRA: Atara Biotherap

23 Jan 26 15:59
LAST:

5.250

CHANGE:
 0.22		OPEN:
5.000		HIGH:
5.348		ASK:
13.150		VOLUME:
292.1K
CHG(%):
4.40		PREV:
5.000		LOW:
4.900		BID:
17.500		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Jan 264.9805.3484.9005.220363.6K
22 Jan 264.5805.1504.4605.000570.0K
21 Jan 264.3404.6904.2004.600418.4K
20 Jan 264.5004.7904.2504.320597.7K
16 Jan 264.7205.0034.5204.540509.3K
15 Jan 264.5205.1904.4004.6201.1M
14 Jan 264.5004.8204.3604.470871.1K
13 Jan 265.9505.9604.2524.3702.5M
12 Jan 265.6206.5105.5805.8554.46M
09 Jan 2617.68017.98013.08013.670852.2K

PROFILE

Name:Atara Biotherap
About:Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Kettering Cancer Center, and Council of the Queensland Institute of Medical Research. Atara Biotherapeutics, Inc. was incorporated in 2012 and is headquartered in Thousand Oaks, California.
Sector:Healthcare
Industry:Biotechnology
Address:1280 Rancho Conejo Blvd, Thousand Oaks, CA, United States, 91320
Website:https://www.atarabio.com
CUSIP:046513107
CIK:0001604464
ISIN:US0465131078
FIGI:BBG005Q3MQY4
LEI:549300WBXUXZRE03MS38

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:5.08 
Forward P/E:33.39 
PEG Ratio:-0.19 
Price to Sales:0.55 
Price to Book:-2.94 
Profit Margin:0.03 
Operating Margin:0.27 
Return on Assets:0.16 
Return on Equity:0.88 
EPS Ratio:2.94 
Revenue:188.67M 
EBITDA:23.98M 
Shares:7.21M 
Market Cap:37.85M 

TECHNICAL INDICATORS

MA5:4.7410.9%
MA10:5.677.9%
MA20:11.35116.3%
MA50:13.55158.2%
MA100:13.59158.8%
MA200:11.28114.9%
STO9:41.10
STO14:6.07 
RSI14:19.52 
WPR14:-93.14 
MTM14:-11.64
ROC14:-0.69 
ATR:2.04 
Week High:5.351.9%
Week Low:4.2025.0%
Month High:19.15264.7%
Month Low:4.20114.9%
Year High:19.15264.7%
Year Low:4.2025.0%

RECENT SPLITS

Date Ratio
20 Jun 20241-25